MedPage Today

Next-Generation Sequencing on Fine Needle Aspirate Biopsies: Diagnostic and Therapeutic Utility for Metastatic Prostate Cancer

"In our study, we showed that fine needle aspiration (FNA) biopsy material can be a good source for next-generation sequencing (NGS) for patients with metastatic prostate cancer. Based on these ...
Labroots

Advancing Cancer Research with Next-Generation Sequencing: Custom Panels, Liquid Biopsy, and Methylation Profiling

Advances in next-generation sequencing (NGS) and synthetic DNA technologies are reshaping oncology research by enabling earlier cancer detection, more accurate biomarker discovery, and sensitive ...
ascopubs.org

Effects of socioeconomic status on access to next generation sequencing in patients with metastatic breast cancer.

Association of West African ancestry, reproductive factors, and deprivation with incidence of triple-negative breast cancer among Black women in the U.S. This is an ASCO Meeting Abstract from the 2025 ...
ascopubs.org

Barriers to and clinical outcomes with next-generation sequencing testing in metastatic prostate cancer.

Delays in time to first lenalidomide prescription fill for multiple myeloma. Preliminary results of a combined home and rural outpatient clinic-based infusion program through the Veterans Health ...
ABC7

'Inoperable' lung cancer to non-existent: The role genetic sequencing plays in treating tumors

BURBANK, Calif. (KABC) -- Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier to treat than others. A local father and ...

Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...